Turning Point Therapeutics Files for $296 Million Offering

Turning Point Therapeutics Files for $296 Million Offering

Source: 
CP Wire
snippet: 

On 9/3/19, Turning Point Therapeutics filed the paperwork for a $296 million offering of its common stock. The San Diego based biotech focused on developing small molecule oncology treatments will sell up to 4,500,000 shares. The announcement comes not long after the company's IPO which was announced in April of this year.